Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Euronext Paris  >  AB Science    AB   FR0010557264

AB SCIENCE

(AB)
  Report
SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector news
Communiqués de presse de la société AB SCIENCE
11/23SCIENCE : Equity financing for a maximum of 4 million shares with Alpha Blue Oce..
PU
11/16AB SCIENCE : secures equity financing for a maximum of 4 million shares with Alp..
AQ
11/16SCIENCE : AB Science secures equity financing for a maximum of 4 million shares ..
GL
10/29SCIENCE : Financing of 4.5 million euros through the issuance of bonds convertib..
PU
10/29AB SCIENCE : announces a financing of 4.5 million euros through the issuance of ..
AQ
10/29SCIENCE : AB Science announces a financing of 4.5 million euros through the issu..
GL
10/20AB SCIENCE : announces positive top-line Phase 3 results for oral masitinib in s..
AQ
10/20AB SCIENCE : announces positive top-line Phase 3 results for oral masitinib in s..
AQ
10/20SCIENCE : AB Science announces positive top-line Phase 3 results for oral masiti..
GL
10/20AB Science announces positive top-line Phase 3 results for oral masitinib in ..
GL
10/13SCIENCE : AB Science announces that results from masitinib study AB07015 in seve..
GL
10/13AB SCIENCE : announces that results from masitinib study AB07015 in severe asthm..
AQ
10/13AB SCIENCE : announces that results from masitinib study AB07015 in severe asthm..
AQ
10/13AB Science announces that results from masitinib study AB07015 in severe asth..
GL
09/30SCIENCE : 2020 Half-year Financial Report (english version)
PU
09/30AB SCIENCE : today reports its revenues for the first half of 2020
AQ
09/30SCIENCE : AB Science today reports its revenues for the first half of 2020
GL
09/30AB SCIENCE : today reports its revenues for the first half of 2020
AQ
09/30AB Science today reports its revenues for the first half of 2020
GL
09/14SCIENCE : Presents Phase 2B/3 Study Results in Progressive Multiple Sclerosis at..
PU
09/14AB SCIENCE : Presents Phase 2B/3 Study Results in Progressive Multiple Sclerosis..
AQ
09/14AB SCIENCE : Presents Phase 2B/3 Study Results in Progressive Multiple Sclerosis..
AQ
09/14SCIENCE : AB Science Presents Phase 2B/3 Study Results in Progressive Multiple S..
GL
09/14AB Science Presents Phase 2B/3 Study Results in Progressive Multiple Sclerosi..
GL
09/08SCIENCE : to present results from its AB07015 study in severe asthma at the annu..
PU
09/08AB SCIENCE : to present results from its Phase 3 AB07015 study in severe asthma ..
AQ
09/08AB SCIENCE : to present results from its Phase 3 AB07015 study in severe asthma ..
AQ
09/08SCIENCE : AB Science to present results from its Phase 3 AB07015 study in severe..
GL
09/08AB Science to present results from its Phase 3 AB07015 study in severe asthma..
GL
09/07AB SCIENCE TO PRESENT RESULTS FROM I : 8th Joint ACTRIMS-ECTRIMS Meeting
GL
09/07AB SCIENCE TO PRESENT RESULTS FROM I : 8th Joint ACTRIMS-ECTRIMS Meeting
GL
09/02AB SCIENCE : New independent research reveals that masitinib has direct anti-vir..
GL
09/02AB SCIENCE : New independent research reveals that masitinib has direct anti-vir..
GL
07/08SCIENCE : New results published in Journal of Alzheimer's Disease support masiti..
PU
07/08AB SCIENCE : announces that new results published in the peer-reviewed Journal o..
AQ
06/10SCIENCE : Presentation of the results from AB8939 preclinical program in AML in ..
PU
06/10AB Science announces that results from AB8939 preclinical program in acute my..
GL
05/22SCIENCE : Postponement of AB Science Annual General Shareholders' meeting
PU
05/22AB Science announces the postponement of its annual general shareholders' mee..
GL
05/08SCIENCE : Presentation of the results from the Phase 3 AB07015 study in severe a..
PU
05/07AB SCIENCE : is hosting live webcast on Monday May 11, 2020 on masitinib in comb..
AQ
05/07AB SCIENCE : announces that the European Academy of Allergy & Clinical Immunolog..
AQ
05/06SCIENCE : Authorization by ANSM to initiate Phase 2 study evaluating masitinib i..
PU
05/06AB Science granted authorization by ANSM to initiate Phase 2 study evaluating..
GL
04/30AB Science reports today its annual financials as of 31 December 2019
GL
04/30SCIENCE : AB Science reports today its annual financials as of 31 December 2019
GL
04/07SCIENCE : Letter to AB Science stakeholders on COVID-19 pandemic impact on AB Sc..
AQ
03/31AB Science announces that FDA clears masitinib IND in Amyotrophic Lateral Scl..
GL
03/12SCIENCE : AB Science will present results from its Phase 3 AB07015 study in seve..
GL
03/09SCIENCE : Summary of webcast with Key Opinion Leaders on masitinib Phase 2B/3 re..
PU
03/09SCIENCE : AB Science is providing a summary of the live webcast held on 06 March..
GL
03/09AB Science is providing a summary of the live webcast held on 06 March 2020 w..
GL
03/05AB Science will host a live webcast on masitinib in Progressive Forms of Mult..
GL
03/02SCIENCE : AB Science announces a new fundraising of EUR 12.3 million
GL
03/02SCIENCE : AB Science will host a live webcast on masitinib in Progressive Forms ..
GL
03/02AB Science will host a live webcast on masitinib in Progressive Forms of Mul..
GL
02/20AB Science announces positive top-line Phase 2B/3 results for oral masitinib ..
GL
01/08AB SCIENCE : announces that FDA green-lights U.S. patient enrollment in masitini..
AQ
2019AB Science announces the publication of new results in the peer-reviewed jour..
GL
2019SCIENCE : AB Science announces the publication of new results in the peer-review..
GL
2019AB Science announces publication of three AB8939 scientific abstracts in the ..
GL
2019SCIENCE : AB Science announces publication of three AB8939 scientific abstracts ..
GL
2019AB SCIENCE : announces publication of three AB8939 scientific abstracts in the s..
AQ
2019AB Science provides the summary of webcast with Key Opinion Leaders on masiti..
GL
2019SCIENCE : Webconference presentation on masitinib in mastocytosis
PU
2019SCIENCE : AB Science will host a live webcast on masitinib in severe asthma on M..
GL
2019AB SCIENCE : will host a live webcast on masitinib in severe asthma on December..
AQ
2019SCIENCE : AB Science will host a live webcast on masitinib in severe asthma on D..
GL
2019AB Science will host a live webcast on masitinib in severe asthma on Decembe..
GL
2019AB SCIENCE : provides the summary of webcast with Key Opinion Leaders on Indolen..
AQ
2019AB Science provides clarification regarding the article published yesterday i..
GL
2019SCIENCE : AB Science provides clarification regarding the article published yest..
GL
2019SCIENCE : Webconference presentation on masitinib in mastocytosis
PU
2019AB Science announces positive top-line Phase 3 results for oral masitinib in..
GL
2019SCIENCE : AB Science announces that AB8939 receives Orphan Drug Designation for ..
GL
1  2  3  4  5Next